59 related articles for article (PubMed ID: 2935687)
1. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
2. Does the CLL B lymphocyte correspond to expansion of an immature B clone or to expansion of a distinct subpopulation of B cells?
Dighiero G; Binet JL
Blood Cells; 1987; 12(2):385-97. PubMed ID: 3113518
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).
Kimby E; Axelsson B; Björkholm M; Gordon J; Holm G; Mellstedt H
Med Oncol Tumor Pharmacother; 1985; 2(4):261-7. PubMed ID: 2935687
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic immunoglobulins in chronic lymphocytic leukemia B cells.
Pianezze G; Gentilini I; Casini M; Fabris P; Coser P
Blood; 1987 Apr; 69(4):1011-4. PubMed ID: 3103709
[TBL] [Abstract][Full Text] [Related]
5. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
[TBL] [Abstract][Full Text] [Related]
6. B-CLL cell surface markers and mitogen-induced thymidine uptake: a comparison between lymph node cells and peripheral blood lymphocytes in 25 patients.
Juliusson G; Robèrt KH; Biberfeld P
Hematol Oncol; 1985; 3(3):165-72. PubMed ID: 3899893
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
8. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
9. 3H-thymidine uptake in chronic lymphocytic leukaemia cells.
Simonsson B; Nilsson K
Scand J Haematol; 1980 Feb; 24(2):169-73. PubMed ID: 7375818
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
Herrmann F; Wirthmüller R
Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia.
Simonsson B; Terenius L; Nilsson K
Cancer; 1982 Jun; 49(12):2493-6. PubMed ID: 7074566
[TBL] [Abstract][Full Text] [Related]
12. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
Gerdes J; Naiem M; Mason DY; Stein H
Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody reactive with human peripheral blood monocytes.
Breard J; Reinherz EL; Kung PC; Goldstein G; Schlossman SF
J Immunol; 1980 Apr; 124(4):1943-8. PubMed ID: 6988511
[TBL] [Abstract][Full Text] [Related]
14. Idiotype-bearing lymphoid cells in plasma cell neoplasia.
Mellstedt H; Holm G; Pettersson D; Peest D
Clin Haematol; 1982 Feb; 11(1):65-86. PubMed ID: 6978789
[No Abstract] [Full Text] [Related]
15. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.
Reinherz EL; Kung PC; Goldstein G; Levey RH; Schlossman SF
Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1588-92. PubMed ID: 6966400
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
